Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516678) titled 'Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma' on April 1.
Study Type: Observational
Primary Sponsor: Sun Yat-sen University
Condition:
Neuroblastoma
Recruitment Status: Recruiting
Date of First Enrollment: January 1, 2022
Target Sample Size: 200
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07516678
Disclaimer: Curated by HT Syndication....